CLA-2-29:S:N:N1-F:238 873448
Mr. Edmundo Rodriguez
Nestor Reyes, Inc.
P.O. Box 4528
Old San Juan Station
San Juan, PR 00902-4528
RE: The tariff classification of Finasteride (the active
ingredient of Proscar, a formulated oral medication for the
treatment of benign prostatic hyperplasia), in bulk form, and
Proscar, in tablet form, from England.
Dear Mr. Rodriguez:
In your letter dated April 9, 1992, you requested a tariff
classification ruling.
Finasteride (CAS registry number 98319-26-7) is the active
ingredient of Proscar, which is a formulated oral medication used
in the treatment of benign prostatic hyperplasia. This product
will be imported in bulk form.
Proscar is a formulated oral medication, in dosage form,
incorporating Finasteride (the active ingredient). It is used for
the treatment of benign prostatic hyperplasia. This product will
be imported in tablet form.
The applicable subheading for Finasteride, in bulk form,
will be 2933.79.5000, Harmonized Tariff Schedule of the United
States (HTS), which provides for heterocyclic compounds with
nitrogen hetero-atoms(s) only; nucleic acids and their salts:
lactams: other lactams: other: other. The rate of duty will be
7.9 percent ad valorem. The applicable subheading for Proscar
will be 3004.90.6015, HTS, which provides for medicaments ...
consisting of mixed or unmixed products for therapeutic or
prophylactic uses, put up in measured doses or in forms or
packings for retail sale: other: other: other: antineoplastic and
immunosuppressive medicaments. The rate of duty will be 6.3
percent ad valorem.
This merchandise may be subject to the regulations of the
Food and Drug Administration. You may contact them at 5600
Fishers Lane, Rockville, Maryland 20857, telephone number (202)
443-3380.
This ruling is being issued under the provisions of Section
177 of the Customs Regulations (19 C.F.R. 177).
A copy of this ruling letter should be attached to the entry
documents filed at the time this merchandise is imported. If the
documents have been filed without a copy, this ruling should be
brought to the attention of the Customs officer handling the
transaction.
Sincerely,
Jean F. Maguire
Area Director
New York Seaport